Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Zivo Bioscience ( (ZIVO) ) has provided an update.
On December 19, 2025, Zivo Bioscience’s Chief Financial Officer, Keith R. Marchiando, resigned effective immediately and agreed to end his employment with the company on December 31, 2025, under a separation agreement that provides him with his current monthly salary of $27,040 through December 31, 2026 and allows him to retain previously granted stock options to purchase 150,000 shares at $7.96 per share exercisable until June 30, 2027, alongside standard release, confidentiality and non-disparagement provisions. To maintain continuity in its finance function, the company appointed veteran biotech finance executive William A. Sullivan, 54, as Interim Chief Financial Officer effective December 19, 2026, under an independent contractor services agreement paying $285 per hour for an initial 60-day term with automatic month-to-month renewals and restrictions on solicitation and business diversion, signaling Zivo’s reliance on specialized life sciences financial expertise during this management transition.
Spark’s Take on ZIVO Stock
According to Spark, TipRanks’ AI Analyst, ZIVO is a Underperform.
Zivo Bioscience faces significant financial challenges, including negative equity and cash flow issues, which are the primary factors in its low score. Despite some technical indicators showing neutrality, the company’s negative valuation metrics further impact the score. Urgent financial restructuring is necessary for sustainability.
To see Spark’s full report on ZIVO stock, click here.
More about Zivo Bioscience
Zivo Bioscience, Inc. operates in the life sciences and biotechnology sector, focusing on developing and commercializing bioscience solutions, with its leadership and financial management closely aligned to industry-experienced executives.
Average Trading Volume: 1,144
Technical Sentiment Signal: Sell
Current Market Cap: $37.89M
For a thorough assessment of ZIVO stock, go to TipRanks’ Stock Analysis page.